| 000 | 01660 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516100127.0 | ||
| 264 | 0 | _c20121105 | |
| 008 | 201211s 0 0 eng d | ||
| 022 | _a1096-8652 | ||
| 024 | 7 |
_a10.1002/ajh.23272 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZaja, Francesco | |
| 245 | 0 | 0 |
_aLong-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _cSep 2012 |
||
| 300 |
_a886-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlatelet Count |
| 650 | 0 | 4 |
_aPurpura, Thrombocytopenic, Idiopathic _xblood |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aSalvage Therapy _xmethods |
| 650 | 0 | 4 | _aSplenectomy |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aVolpetti, Stefano | |
| 700 | 1 | _aChiozzotto, Marianna | |
| 700 | 1 | _aPuglisi, Simona | |
| 700 | 1 | _aIsola, Miriam | |
| 700 | 1 | _aButtignol, Silvia | |
| 700 | 1 | _aFanin, Renato | |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 87 _gno. 9 _gp. 886-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.23272 _zAvailable from publisher's website |
| 999 |
_c21882282 _d21882282 |
||